Matthew Starr, MD

Assistant professor of ophthalmology and the Program Director of the residence program at the Mayo Clinic

Articles by Matthew Starr, MD

ASRS 2025: A look at secondary scleral-sutured toric intraocular lens for astigmatic correction in the absence of capsular support

ByMatthew Starr, MD,Martin David Harp,Sydney M Crago

August 4th 2025

Q&A: Matthew Starr, MD, shares insights into RHONE-X trial

ByMatthew Starr, MD

May 22nd 2025

Matthew Starr, MD, highlights the RHONE-X trial's findings on faricimab, showcasing improved vision and reduced treatment burden for diabetic macular edema patients.

Latest Updated Articles

ASRS 2025: A look at secondary scleral-sutured toric intraocular lens for astigmatic correction in the absence of capsular support
Published: August 4th 2025 | Updated:

Matthew Starr, MD

Articles by Matthew Starr, MD

ASRS 2025: A look at secondary scleral-sutured toric intraocular lens for astigmatic correction in the absence of capsular support

Q&A: Matthew Starr, MD, shares insights into RHONE-X trial

Latest Updated Articles

Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

REGENXBIO completes enrollment in ATMOSPHERE and ASCENT trials of sura-vec in wet AMD

Increasing the knowledge base of GA is key to individualizing patient therapy

Academy technician training platform expands education opportunities in ophthalmology

Quantifying intermittent retinal capillary perfusion in RVO and PDR

FDA clears IND for Complement Therapeutics’ CTx001 gene therapy in geographic atrophy